What happened at SLEEP2025? AI, Meds, and New CPAP therapies!

Sponsor Intro and Show Milestone 0:00

Lights out. Now a word from our sponsor, MedBridge Healthcare. Medbridge Healthcare is a leading provider of sleep lab management services and home sleep apnea testing. MedBridge partners with hospitals, healthcare systems, and medical academic institutions to offer comprehensive, fully integrated services for sleep disorders. Welcome everyone once again to another episode of Sleep Tech Talk, the sleep podcast with your hosts and friends, Emerson Kerr, Robert Miller, Folks, we've got a very special episode today, but before we get started, We just want to say thank you so so much for all the support you've been giving us.

Three years, 100 episodes, and counting. Thank you, so, much, for that.Thank you for, all, the likes. thank, you For all comments and subscriptions, But most importantly, thank You so Much for sharing the podcast with all The friends that are out there. With that being said, let's talk about Sleep in Seattle. Sleep 2025. No pre-cals needed today. We're just jumping right in. Yeah, we're jumping in, that's right. A lot to talk about. If we don't mind, I'd like to start off the conversation with the presentation that you two gentlemen did for the AAST portion of the conference.

Fisherman Peckel Solo is the world's first autofit CPAP mask. It simplifies setup with its revolutionary auto-lock technology. Simply stretch to fit, touch to adjust.

Sleep 2025 Conference Recap 1:58

Go to fphcare.com forward slash solo. That was incredible. So Rob, you dove in first. You had the lion's share of the presentation. Yeah, you know what, it was an opportunity. And I have to say that, first of all, thank you to the people who attended our Sunday afternoon session. I think we were really overwhelmed to have 180 people that came in and listened to our presentation, where we talked a little bit about Where sleep how sleep diagnostics has evolved where things were in the past where it is today and where what it what that might look like in The future and then we also talked about sleep therapy, you know the progression of sleep, therapy over the years as well and It was, you know, one of the things that I offered at the end of presentation was for anyone to send me a message and I would send them a copy of our presentation.

I had over 50 people reach out to me and ask me for a of a presentation, so I think that the content was well received and, I have to say, for my friend Emerson, it might have been one the most inspirational, sleek technology, just his wrap up of of the presentation itself, but then sort of setting the tone for sleep techs and sleep technology going forward. Probably one of most motivational speakers, Emerson, you did an amazing job. I was fired up, I think the audience was fire up after your part of presentation, and I know that you set the tones for probably the rest of conference from an AST perspective.

Uh, thanks, Robert. It was, you know, I think we, especially when you look at the body of what we were doing there is it's so easy to look. At innovations. And we talk about this a lot here on sleep tech talk is innovation can be intimidating and, and we see a of it and a a is happening and you said it during my talk, during your talk. But then I say it often, people take care of people. and I that's why sleep technology as a field will continue to be a thriving but evolving field for us. And I think that's the important part of this is that as we go forward and think about where we're headed as a community, we have to keep that in mind, but we absolutely got to continue to look at what's on the horizon and how do we incorporate it into what we do.

That was really the key message there of where were headed. But no, 180 people, for our presentation. The series of speakers that we had was by design. Really had some, most of them were guests from the show. So that was outstanding. But we did have a few that have not been on the shows yet, like Alex Gomez and Chris Hope, both physicians in sleep. You know, really and truly just an incredible lineup of the speakers. And really the overall show was fantastic. I think I've already heard there were over 6,000 attendees at the show, putting it on par with the largest meeting that Sleep has ever had.

So I think we're still waiting on what those final numbers are, but we are right on part with largest show ever that was in Boston several years ago. But the exciting thing about it is that sleep is back. You know, the sleep technologists were back and sleep is back to where it was pre pandemic, which is fantastic to hear. But to say the Sleep Technologists we're back really had an impact. You a lot of the vendors saw that their booths were busier than they've ever been. I remember on the last day I was actually in the booth there with Knox and usually that is just a dedicated dead day and then entire morning we were busy.

So. really positive to see that is that the sleep technologist impact was felt in every corner of the meeting and that's what we hoped. But you're right, I think the way you and I kicked it off set the right tone and really allowed things to carry forward in such a special way. So Robert, sorry, Emerson, let me ask you that. When you say sleep is back, can you elaborate a little bit on that for our audience? Well, I think, you know, if you've been to any of the conferences, we all go to the regional ones, and we've all been the national ones.

And the volume of people has just been slowly, year over year, growing since 2020. We obviously took a massive hit. because of the COVID and the things that went with that for obvious reasons. So I think to say sleep is back, it's good to see the numbers again, back to that all-time high that we saw at pre-COVID levels. And then sleep technologists have been as an organization, the AST in particular, has not been a part of Sleep or the APSS now for several years. And so this was the first year that the AST was a participating membership body in the Sleep Conference.

That is all thanks to the to the ASM and to SRS. All three of those, even though the ASMR and SRR make up the APSS, the three together made the decision and we're very grateful for their allowing us to be there. And they're going to have us back in Baltimore next year. So we live up to our promises. We delivered a great, great content, a meeting. and brought people here that wouldn't have been here otherwise. So all wins across the board and exciting for what's going to be coming in Baltimore next year.

Robert, what are your thoughts on that? You know, I love it. And honestly, between the time that a decision was made for the AST to sort of rejoin the ASM and be a part of this meeting and actually pulling all of the speakers together, there really wasn't a ton of time for us to really truly promote the sleep tech track to sleep texts and get them to get more involvement. I think with more preparation, more time next year, and a real commitment to really change the AST from who we are in the industry standpoint, I expect the attendance for the sleep techs to be even higher next.

So with that being said, that's huge for all of us to look forward to what is going to happen in future. But talking about the future, what do we see at sleep? Well, there's a lot to see. One last thing before we transition to that. Congratulations to Robert. He is now the secretary treasurer of the AST and really looking forward to serving with him in that role as I'm still president for one more year. So big congratulations to robert for stepping into that roll of leadership with the ST. Huge shout out to your brother for for Yeah, we've got some new board members also that joined.

New Technologies and Pharma at the Expo 9:20

And it was awesome. It was fun to be a part of some of the awards that were given out at the beginning of AST or the Sleep Tech track. So I'm excited about what the AAST can be reinvented into. But no, you're right. There was a lot going on there that was new. We got to see the K-pop. You know, We've had them on Dr. Noah. And Dr. White and Dr Gaon talking about this before. So it was really exciting to see the activity in their booth. I think one of the things that stood out was that anyone who had new technology and new innovations really were drawing a lot of attention to themselves.

If you didn't and you were really kind of same old thing, the booth really wasn't busy. So I think that was really a telling sign in this. But that one in particular, a shout out, I there was some other activity with some of the other vendors as well that had some new things to the market. So, Robert, you got around a little more than I did, but I certainly saw that. Yeah, I think Jerry and I may have been together, we went by rest vent and they had this really interesting new travel path that it's not available yet, but it is coming.

And it was probably one of the just high quality, it designed very well, you know, sort of a small round. a travel PAP device that sits on top of and it's part of what can be provided to the patient. Let me say this, I think that it can technically be the patients primary unit and then also the travel path as well. It's small enough to be able to serve both purposes, but then it sat on a small round battery that was designed to a holder, a cradle for the PAPP device. Really interesting technology.

There was also another company, it was a Chinese manufacturer that had a device. It's sort of funny because they were carrying it around in a bag. I did get to see it, but they didn't have a booth. There's a company Murata that has a new travel unit that they're working on. and some interesting technology there as well. So, you know, I think that, like you said, Emerson, the booths where there was an introduction of new product, new services, had more traffic, and especially if there were innovation.

Every time I went by the K-PAP or the Sleep Res booth, were standing there listening, going through sort of the class that was being taught with the whiteboard. Dr. Ngo is famous for the for white board sessions. And I'm certain that they were completely exhausted at the end of every day with all the traffic they had in their booth. But we can't leave out pharma, pharma, Pharma. I was just going to bring that up. What did you guys see over there? Well, it was all about, I mean, the buzz through the whole meeting was either about Aptimid and their forthcoming drug or Trezapetide, ZetBound.

And at some of the cocktail parties that I attended, the leading physicians were talking about how it's impacting their practice, what it is doing. And so I think we've talked about it some on the show before of how this is going to change sleep. And that conversation is happening among our key opinion leading doctors of it's changing their practice. So I think physicians that are coming to the meeting are really beginning to pay attention. What are the thought leaders doing? How are they going to use it?

I wish every physician could because as we've talked about on the show before, we hear stories of how people are using it poorly. and are not using it wisely on people that certainly need CPAP. But it was the prevailing conversation was just Pharma, Phasma, pharma across the whole show. Well, and even, you know, if you take into account just booth size, um, If you remember at last year's sleep meeting, Lily was like a 10 by 10 over on the side, sort of tucked away. They were there, but not, not out front.

And, this year, 20 by 20 with the whole, build out, exhibitor space, they're they're going to be a player. And one of the things that I sort of took away also is that if you think about direct to consumer advertising for sleep apnea, we've talked about this on the show before too, that Inspire and all of that advertising that they do has helped to elevate and bring all ships rise with all the advertising they've done in bringing awareness to sleep Apnea. Lily's just getting started. It's going to continue to be interesting.

If you remember right before sleep, I think they actually published some preliminary results of a clinical trial that they're doing on a pill form of ZetBound, which essentially had the same clinical efficacy as the shot version that people take today. If I heard it correctly, I think that I've heard that it would be sometime next summer that we would see the pill form. And I'm assuming that that would allow for more patients to have access to that medication and maybe make it more affordable. So let's take a minute.

I hope so. Yeah, exactly. More affordable, most definitely. But with that being said, let us take couple of minutes to talk a little bit about the Abnomad booths and what's going on over there. You know, it's funny for me with Abnomad, I had an opportunity to meet their chief commercial officer and, you know him and I, had exchanged some emails and spoken before the sleep meeting, but we had some time to sit down and really talk. And I think that we're going to see Abomad be very collaborative with with DME providers.

You know, I don't think that they're out to try to steal every single OSA patient that gets diagnosed. I think their target patient population for the most part to begin with will be the non-adherent PAP patient. My hope is too that it's a great co-therapy for a patient who's on CPAP pressures that are extremely high. Maybe this is a way to open the airway, reduce the pressure, give patients the ability to be more adherent to their CPAT. So we'll see. But they're contributing to the field of sleep medicine and don't have a product to sell yet.

I agree with you. There's a lot of questions. I think there's more questions than answers right now. But I this goes back to what I said a few minutes ago about the GLP-1s. And if we think about one of the things that needs to become a part of this conversation is why positive airway pressure does work. As we learn more about endotypes and what AI is teaching us from that, and I think that's where the conversation needs to go next is if we're going to be moving in the direction of pharma, then who is the real candidate?

And I hope that a conversation that begins to bubble up in this is that it's not a one size fits all. It's for everyone. Some people have a floppy airway and need airways support with positive air way pressure of some kind. And so I do hope happens, but it is fascinating. to see how physicians that you never thought would move away from this piece would do that. But we're also seeing in that conversation, this is another sleep tech talk topic, is women in sleep. I hosted a symposium that was sponsored by Knox.

And one of the facts that came out of that is that it wasn't until 1993 that any research, medical research was done on women. That is the blew my mind, that we have been really leaving women behind across all of healthcare, not just sleep medicine. So that's a topic that really started at Sleep 2025 this year. And I think we're gonna see it grow over this next year, I know it's our priority to the Academy and it certainly to a lot of people, but That was another part of this. And it kind of all goes together with these phenotypes is as we discover these things, how do we change what we do with medicine to be more specific for the kind stakeholder or patient that we're working with?

You know, Emerson, you're talking about that sort of thing. And what I found interesting this year was there was a lot of presence of patient advocacy this here. What are your, both of you all, what are you thoughts on that? Our good friend Emma was front and center with that, yeah. You now, one of our alumni here on Sleep Tech talk, she was definitely there. She was the speaker. We certainly got to see her in our influencers breakfast that we had with Teresa Powers and those guys. But no, that was really great to.

Let's not flow right by that. Yeah, we don't want to, That was a great, great little meeting. This is the first year that Sleep Tech Talk has been a part of a content creator session that that, was hosted by Teresa Power. Sleep Better New York. And she did an amazing job of putting together just a nice breakfast reception. There was lots of photos, and it gave people who are committed to content and patient advocacy and all of those types of things an opportunity to meet each other, even though we live in this virtual space.

It gave us a chance to be each in person. I think it was the beginning of something, you know, Teresa calls it like her favorite Monday of the year or something like that. And I, I might be our favorite, Monday, of, the, year going forward as well. And it was so fun because so many people in there, almost all of them, maybe a handful have been guests on the show. So it's almost like a family reunion for us to see old friends and get to take pictures with them.

Patient Advocacy, Womenu2019s Sleep Health, and Diagnostics 19:48

And, it, was just a really beautiful experience. But no, seeing Emma there was always, she's always a delight and really kudos to Teresa. for such a great breakfast. And it really did seem like a family reunion with everyone, and just imagining how that's going to continue to grow from year to year. So big shout out to Teresa. Great job for pulling such great little breakfast time together. That was pretty awesome. Yes. All right. For the audience out there, we will have some of those pictures out on our social media for everybody to check out and see what kind of fun we have there.

With the smiles. Exactly. But yeah, what else did we see in terms of patient advocacy and, you know, like you said, the inclusion of women in the space of sleep health. Well, I think one of the things that was interesting and really talking to some of people that were in that space is how there were even mixed reviews about that. You know, some people didn't care to have a patient advocate there and that's something that is going to change and it's part of dialogue that we've got to in sleep is, what is the patient perspective?

You know, in manufacturing, we talk about the voice of the customer. Well, they are the voices of, you know when we think about what sleep, is and so I was very happy to see that. I hope that continues to grow and we continue to hear more from people like Emma and everyday people, maybe that aren't as social celebrities as she is, but they're just everyday. I hope that grows for sleep and that we hear more from patients who are really representing the voice and mind of what the sleep apnea patient goes through and lives with.

Fisher & Paykel Healthcare is a leader in CPAP mass design and innovation for over 20 years. Their unique technologies have benefited millions of OSA patients through their top CPAP masks. These advancements continue to further enhance patient experience and outcomes. Looking for new opportunities? Well, MedBridge Healthcare is one of the largest employers of sleep technologists and they are growing. If you are a sleep technologies interested in a new position, potential paid relocation, or looking for a career advancement, consider a Career with Medbridge Healthcare.

Now back to the show. You know, if you go all the way back to some of our early episodes, we had Dr. Valerie Caccio on the program who has a women's sleep health practice, albeit virtual. And she was at the content creators event as well. So we got to meet her in person for the first time. We need more of that, but we have to keep talking about it and bring focus to it because women's sleep health. And if you remember with the conversation with Dr. Caccio, she said sometimes it was more important to treat other factors for her female patients before she addressed the sleep apnea because she had to address some of the hormonal things and maybe even some lifestyle or social issues that a female may be going through that are contributing to the overall sleep challenge.

And she just wanted to make sure that her female patients were in a place that they would accept CPAP therapy if that's what was needed. But more of a holistic approach to taking care of these ladies. I'd like to say that I saw a lot more leaning towards obstructive sleep apnea this year as opposed to other years. You would see a lots of pharmaceutical companies addressing other sleep disorders, but this years there was a heavy leaning toward obstractive sleep Apnea. Did you guys feel the same way about that?

I think it goes back to what they're seeing from the GOP1s, you know, surprising outcomes data with trisipatitis, I thing is important. And that elevates this, because in the past, pharma is really going to be for narcolepsy and insomnia, and those, we're certain, are still going be important, They're still important things. I mean, more insomnia than anything else is what we deal with in sleep and society. So those are still going to continue to be important. But I think these new findings of what they learned from the study with Dr.

Malhotra really elevates this to another level of, you know, where can this really take us? Because I think we're going to continue to learn more about the impact of these drugs, because there's more in the pipeline. Yeah, there are more combinations of drugs in a pipeline, and as we begin to see those come to market, what are the long-term effects of those, not just with sleep apnea, but other comorbidities? And how are they going to change the lives of countless people? So I think we're going see more about sleep apnea at this simply because they're seeing this effect and what these combinations of drugs, because I mean, it's not far fetched to begin thinking, you know, how would you mix apne med solution with you know, Lily solution.

And now you've got a great combination drug to control weight loss and clearly sleep disordered breathing. Where will that take us? What opportunities does that offer patients and caregivers? Also, I have access to a physician who is pretty tied in with pharma, and he says that there are other GLP medications that are on the horizon that even much more effective and better from a side effect standpoint than what terzepatite is today. I have a, I've actually put together a presentation recently where I wanted to put, you know, put it down so that it was a visual for us to be able to see, what are the therapies that are currently available for patients from a sleep therapy perspective?

And what's the efficacy? So that's, it's very easy to say all in a couple of slides, where things stand. So CPAP still at the top of the list, but the last two pages are all pharma solutions that are in development. So, you know, we've only got one that's FDA approved today. We know that ApnoMed is fast-tracked to get FDA approval as well. But, in my research, there's probably 12 to 15 pharmas treatments that in some form of clinical research today, You know, the thing I think that sort of leaves side at me and it sort takes us back a little bit to some of the other part of our conversation is that you just said, you know we're looking at outcomes around how these therapies work and something I wish that would change.

And we talked a bit about this before we got on the show today, but I wished the same kind of testing would happen with diagnostics. Because one of the things we're seeing, and it can be really exciting when we talk about innovation, is these new types of testing devices for patients. And we all agree, a lot of these over-the-counter solutions that you can get at Best Buy or through Apple are just that. But some of those things that people claim are FDA approved, I think people really don't understand what that means.

And it really has come to light as we see a lot of these things at the show. They're fun to see and they're exciting. But FDA approval really just means that the device lived up to the claims that were made in the application. It doesn't mean that it's effective. it doesn' mean the science behind it is solid. There's no validation into it from the FDA. They don't go out and test it to say, okay, Emerson, this product you say does what it does. Yeah, it doesn't work that way. And I wish that one of the things that would start happening is that we would take a harder look at technology that And I know there are physicians that are thinking about that.

I talked to a few at the show that they wish they could put all of these different things on one patient. He said, I wish I could every PPG, every cardiopulmonary coupling or PAT device, rip all them on patient at a time. But those kinds of studies are so expensive and they're so time consuming because you've got a massive amount of data per patient that you're having to collect and compress and compare. But that's something I wish that would change is that we would be more mindful about the technologies we embrace to test patients because not every solution for testing works with every gender or every race.

And I think that one of the things that got to be really explored in the coming years is we get a little bit more I don't even know what the right word is at the moment, but we're careful about what we use to diagnose patients. And I think that that's something that is really left out at this meeting is we need to take more time to do more validation around technologies that we are diagnosing people with. Because I the big question that came to my mind, especially in the symposium I led, is if it was your grandmother, mother, daughter, wife, What would you do if you were testing?

What Would you choose to want to know about their sleep disorders or their waking disorder? Would You settle for good enough? Or would You want great? And I think that was something that really stuck to me this during sleep meeting is where it's sort of like the old book good to great, you know, good is the enemy of great. Well, I think we're doing that in sleep diagnostics. We're saying it's good enough. Well I wouldn't want good for my mom. I would want great for mom, and I'd think that we should have that same attitude about patients.

And I know I'm soapboxing a little bit, but that was something that really jumped out at me during the sleep conferences. we've got to really look at that and take a harder look what we are doing with sleep diagnostic. I mentioned to you, Emerson, I think you and I talked about this, that I never want a sleep test to become a pregnancy test for sleep apnea. And some of the black box technology certainly feels like it's a pregnant test or sleep Apnea, but I appreciate companies like a Huxley Medical that's trying to figure out how do we take some that same information and in a high resolution format, bring in cardiac monitoring piece.

So now they've got a device that not only can be used for sleep testing, but also might be use for cardiac monitor as well.

Oral Appliances and Combination Therapy 30:48

Just bring more science to the table with these new technologies. Absolutely. Talking about new technologies, let's take a moment to talk about dental appliances. I saw a lot more this year. Would you agree with that? Well, I think the need for presence there, we saw our good friend Dr. Sue Ellen Richardson get an award, a fellowship. That was fantastic to see. So congratulations, Dr Sue. Ellen. I it's something that is becoming more and more prevalent because the science is better around the different technologies.

You know, spent a year working in that space. It's, I think there's an awareness that's growing about their effectiveness. And that is really exciting to see, but the adoption still isn't there yet. I hope that does change as we have better testing. that as we're talking about, that's more, I think the word I was looking for is discriminatory, even that it's kind of a harsh word. But as have better testing, one of the things we'll discover with our phenotyping and endotyped is how those devices fit better in the lives of certain patients versus others.

We're so stuck with the paradigm of it has to be done a certain way, we've got to follow a that we kind of push oral appliances to our safety net. Well, if they fell CPAP, then we should do oral appliance. That's really backwards. It really should be which is the technology or which solution should we put with the patient that has the problem that solution addresses. And it isn't always CPAP, even though the three of us have had a career with CPAPP and we're thankful for that, it is an always the best solution.

And I think that people are beginning to see that plus oral appliances are better than ever. A lot of great innovation there and it's exciting to that. Yeah, and I would also mention Emerson. I know it can be a slippery slope with some of the telehealth dental services that are out there, but they are doing some significant direct to consumer marketing and creating a lot of engagement. And you see a company like a Daybreak that has gone from zero to one of probably one the largest oral appliance companies in the country.

So to me, it shows that there is still a lot more demand out there for that type of therapy for patients that they want. It's just a matter of how do you deliver it to them in a way that clinicians can all agree on. And even for a non-adherent CPAP patient, I think that it's an unfortunate circumstance. A lot of the companies just, once the patient has turned in their CPAPP device, there's no secondary follow-up to offer that patient a solution that they might be able to use. And going back to your point, it would have been good to have determined that on the front end versus trying to do it in follow up.

I think that as we see things short term, midterm, long term oral appliance therapy in conjunction with some of the pharma treatments, I, think is going to be a significant co-therapy. Well, I think that that last point is the most important point, is that combination therapy, and one of the things that we really need are studies to validate that, because that doesn't exist. Even though we'll see a combination of oral appliance and CPAP, there's no studies that either side, whether it's a PAP company or an appliance company can really claim that says these two things work together and stated out there as a legitimate claim, even though the anecdotal evidence is there.

And so that's little frustrating if you're a clinician and you want to do right by your patient and be the patient advocate. So I think that one of the things we also need is some of those validating tests that say using oral appliance with CPAP or using rural appliance, with a pharmaceutical has a better outcome because, you know, one of my good friends from New Jersey. Dr. DeFederici, he told me once that for every millimeter you move the mandible forward, it opens the airway three millimeters.

Well, that's fantastic. But most people don't know that. And so we've got to think in terms of what's right for the patient because it is effective, but we need more studies on the combination therapies to really pull this forward the way it could be. Yeah, and it's funny because we actually had someone go back to an older episode of Sleep Tech Talk and pull out something that I said and posted it as a post on LinkedIn. And it was me sort of advocating for oral appliances because my own personal journey is that, I was a longtime CPAP user, went on a GLP-1 lost weight and still felt like I needed a little something extra.

My sleep apnea was never severe, but it was about snoring primarily for me. Today I'm an oral appliance guy. I wear an oil appliance every night, have been able to maintain my weight, which has been great. Patients are going to be a little more, I don't want to say complicated in the future, they're going be very nuanced in how you have to treat the patient. Agreed. And I think that's very important because based on what we've been talking about right now, I'd think, that you could kind of sum up the entire conference about that.

The fact that this is more tailored to people in general, the different types of people rather, what's right for each different person. But with that being said, before we close, but about sleep tech talk at the conference, What are y'all's thoughts about Well, you know, first of all, we don't talk about this much, but just a special thank you, Robert, for being the vision for this show. When you reached out to Jerry and then me to be a part of this, We had no idea where this would take us. And so it was so fun to not only have our jobs that actually support our lives and our families that we were there for and be enjoyed, but to be able to part of conversations that Sleep Tech Talk has created at the meeting and some of the fun conversations we have with people who are fans of this show that went out of their way to tell us how much they enjoyed it was such a special moment because it's easy for us.

We see the 50,000 subscribers, you know, when you get to talk to those people and they tell you about a show that they enjoyed, it really means so much to us because, you now, as far as we know it's just the three of us talking. And to really have that, It means a lot to use. It was really, really nice to see that in Seattle. Fisher & Paykel Solo is the world's first autofit CPAP mask. It simplifies setup with its revolutionary auto-lock technology. Simply stretch to fit, touch to adjust. Go to fphcare.com forward slash solo.

So your thoughts Robert? Oh, yeah. So, you know, the the only thing I was going to say is we got to sign an autograph. Like, that's the first time in my life someone asked for an photograph. It was legit. it wasn't like, he was making fun of us or whatever. But, this guy had a book of sort of his favorite things. And Sleep Tech Talk was one of those things and he asked us to This book that he had carried with him and you know, that was it's very humbling to think that there are people who are regular listeners and You know I always appreciate that Kevin Adley typically when we have a post he he always jumps in and listens to them so quickly and gives a profound He's a guy who's always going to support what we're doing over here.

And then to also see that we've had the opportunity to see a lot of the products and services and things that are new and talk about those things before

Sleep Tech Talk at the Conference and Upcoming Symposium 39:28

they even get to the market, like our most recent episode with Bayou Sleep. An AI mask fitting, custom mask solution for patients, That's not even available on the market yet, but it's coming. And we had the pleasure of having them join the podcast. So all of those things, we're just super grateful and humbled by the You know, the support from the industry and, you know the sponsors that we have. We have MedBridge Healthcare, which has been here from very beginning. Uh, we had React Health that's also been a long time sponsor.

And even our newest sponsor, Fisher & Paykel, were extremely thankful for those three companies. They've allowed us to do some things like we were part of the sponsorship of that content creator. meeting that was held at sleep. And I hope that we can do more things even at some of the state society levels from a Sleep Tech Talk standpoint. So coming to a state's society near you. Well, there's one in particular that will be coming in October. I was just going to say that everybody stay tuned because there is something coming up from SleepTech Talk in terms of a conference, right?

Yeah. Smokey Mountain Symposium. I'll go ahead and spill the beans. Go ahead. The 2025 Smoke Mountain symposium is a sleep and respiratory conference. Sleep Tech Talk has joined up with Encore Health and we will be co-sponsoring the SleepTech track portion. We're bringing in the speakers and you know, engaging with more sleep vendors and really what we really want is more SleepTex to join and attend that meeting so that, and come and be on site. It's in Pigeon Forge, Tennessee, one of the funnest places in the Tennessee mountains.

And beautiful. Yeah, it is beautiful. If you don't like what you find in Pigeon Forge, you can go right over, right down the road to Gatlinburg, which is a completely different mountain town experience. And, I think they even have like a new Jason Aldean bar there in Gatelynburg. So there's something for everybody. Yeah, except don't play you in putt-putt, because you're like a pro at that. Hey, by the way, I didn't come in last. Thank you. I mopped that up. Successfully had the highest score, so I was proud of that We'll give you that one there, right?

No, but I'm excited about that. Our partnership with Zach, also a Sleep Tech Talk alum, is just a step forward. For those of you who have enjoyed the show, we have a great lineup of guests that are world caliber speakers who are going to bring some really phenomenal content. We're gonna do, the three of us are going to do our own panel discussion there, so a lot to look forward to. But yeah, there's nothing quite like being in the Smokies in fall, and we certainly hope that everyone's able to join us there.

Hey, now that we spilled the beans, we'll have information about that in show notes for sure. Yeah, and it's actually already on our website. If you go to sleeptechtalk.com on the very front page down at the bottom, there's a flyer with a QR code that'll take you to the registration page. How about that for efficient communication? Efficient, very efficient communications. Yes. Well, I'm looking at our clock and we are running really, really close out of time. So let us start or close. I just want to say a huge thanks and a shout out to everybody out there listening, making this possible and to Robert saying, you know, that the fans out We say thank you so much for everything that you've done.

All the likes, all the subscriptions, a huge, huge shout out to all our sponsors and partners that are working with us to help us do what we do each and every time we record a show. We can't thank, you know, for that. And until next time, we say lights on. Before we go, We would like to thank our sponsor, MedBridge Healthcare. MedBridge Healthcare is developing innovative inpatient, post-discharge and population health programs to screen comorbid conditions, diagnose and treat sleep disorders. Learn more about their innovative solutions and career opportunities at medbridgehealthcare.com.

Once again, you can learn more Within our Luna PAP device line, each offering is FDA approved, encompassing CPAP, APAP by-level and by level ST models. Our thoughtfully selected array of PEP interfaces and accessories complement our LUNA PAPP device-line while accommodating diverse patient requirements.